Evotec SE (EVO) Gains from Investment Securities (2022 - 2025)

Evotec SE (EVO) reported Gains from Investment Securities of -$2.5 million for Q4 2025, down 105.9% on a YoY basis from $42.3 million in Q4 2024, and down 162666.34% sequentially from $1533.8 in Q3 2025.

Evotec SE (EVO) Gains from Investment Securities (2022 - 2025) Analysis & Trends

Evotec SE (EVO) has 4 years of Gains from Investment Securities data on file, last reported at -$2.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 105.9% year-over-year to -$2.5 million; the trailing twelve-month figure through Dec 2025 stood at $39.8 million (down 23.71% YoY), and the FY2025 full-year result was -$2.5 million, down 105.9% from the prior year.
  • Gains from Investment Securities eased to -$2.5 million in Q4 2025, from $1533.8 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $175.5 million in Q4 2022 to a low of -$2.5 million in Q4 2025.
  • A 4-year average of $22.5 million and a median of $13443.8 in 2023 frame the typical range for Gains from Investment Securities.
  • Peak annual rise in Gains from Investment Securities reached 329.22% in 2024, while the deepest fall reached 137.81% in 2024.
  • Tracing EVO's Gains from Investment Securities over 4 years: stood at $175.5 million in 2022, then tumbled by 94.39% to $9.8 million in 2023, then jumped by 329.22% to $42.3 million in 2024, then sank by 105.9% to -$2.5 million in 2025.
  • Business Quant data shows EVO's Gains from Investment Securities at -$2.5 million in Q4 2025, $1533.8 in Q3 2025, and $42.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.82 Bn 87.96 Bn -
2 Teva Pharmaceutical Industries 36.03 Bn 32.29 Bn 1.97 Bn
3 Zoetis 32.48 Bn 30.54 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.56 Bn 23.50 Bn 4.39 Bn
5 United Therapeutics 23.02 Bn 20.86 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.43 Bn 18.63 Bn 1.16 Bn
8 Neurocrine Biosciences 17.77 Bn 16.46 Bn 800.70 Mn
9 Elanco Animal Health 12.73 Bn 12.30 Bn 785.00 Mn
10 Evotec SE 341.84 Mn 341.32 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.49 Mn
Dec 31, 2025 -2.49 Mn
Sep 30, 2025 1,533.80
Sep 30, 2025 1,533.80
Dec 31, 2024 42.27 Mn
Dec 31, 2024 42.27 Mn
Sep 30, 2024 -6,845.20
Sep 30, 2024 -6,845.20
Dec 31, 2023 9.85 Mn
Dec 31, 2023 9.85 Mn
Sep 30, 2023 18,105.44
Sep 30, 2023 18,105.44
Jun 30, 2023 8,782.18
Jun 30, 2023 8,782.18
Dec 31, 2022 175.52 Mn
Dec 31, 2022 175.52 Mn
Sep 30, 2022 29,179.46
Sep 30, 2022 29,179.46
Jun 30, 2022 -67,015.43
Jun 30, 2022 -67,015.43